Company Profile

TempraMed Technologies Ltd. is a Canada-based company. The Company is engaged in providing temperature-controlled medication storage solutions. It develops patented, FDA-registered, space-grade thermal insulation devices that work 24/7 for years without charging or external power. These devices operate continuously without the need for charging or external power sources. Its product line includes VIVI Cap and VIVI Epi, and the Company is developing a technology platform intended to support the management of temperature-sensitive medications. The Company has operations in North America, Europe, and Asia.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-09-24	$0.4200	+16.67%	27,500
26-09-23	$0.3600	0.00%	6,910
26-09-22	$0.3600	+20.00%	1,000

Delayed Quote Canadian Securities Exchange

More quotes

Market Closed - Canadian Securities Exchange 12:05:54 2026-09-24 EDT			5-day change	1st Jan Change
0.4200 ^CAD	+16.67%		+16.67%	-61.11%

08:53am	TempraMed Technologies Ltd. announced that it expects to receive CAD 1 million in funding	CI
09-18	Tempramed Technologies Ltd. Reports Interim Sales Results for the Month of July, August and Eight Months Ended August 31, 2026	CI

Markets		Quality
Canadian Securities Exchange	VIVI	Delayed
Boerse Muenchen	9DY	Real-time
Tradegate	9DY	Real-time
OTC Markets	TMPTF	Delayed
Deutsche Boerse AG	9DY	Delayed

08:53am	TempraMed Technologies Ltd. announced that it expects to receive CAD 1 million in funding	CI
09-18	Tempramed Technologies Ltd. Reports Interim Sales Results for the Month of July, August and Eight Months Ended August 31, 2026	CI
09-18	Tempramed Technologies Ltd. Provides Earnings Guidance for the Third Quarter of 2026	CI
09-01	TempraMed Technologies Ltd. Signs Letter of Intent with CPO Greece for Exclusive Distribution Of VIVI Cap And VIVI Epi In Greece	CI
08-25	TempraMed Technologies Ltd. Signs Definitive Five-Year Saudi Arabia Distribution Agreement with Black Olives Company for Private-Label Vivi Cap Commercialization Through Nahdi Medical Company	CI
08-20	TempraMed Technologies Ltd. Announces Resignation of Nancy Goertzen as Board of Director and from All Committees, Effective August 19, 2026	CI
08-20	Tempramed Technologies Ltd. and Maccabi Healthcare Services Extends Agreement for Medication Protection Technology	CI
08-18	Tempramed Technologies Ltd. Enters into Definitive Exclusive Distribution Agreement with TEM Consulting International S.A	CI
08-04	Tempramed Technologies Ltd. and Stealth Health Integrate Vivi Product Portfolio into Stealth Health Telemedicine Platform	CI
07-09	TempraMed Technologies Ltd. Products Accepted by Meuhedet Health Services	CI
07-06	TempraMed Technologies Ltd. Signs Non-Binding Letter Of Intent For Exclusive Distribution In Kuwait With Elegir Trading	CI
06-30	TempraMed Technologies Ltd. Expands Distribution Agreement With McKesson Medical-Surgical	CI
06-26	Tempramed Technologies Ltd. Signs Non-Binding Letter of Intent with Rawafed Health International Company for Exclusive Distribution Agreement in Saudi Arabia	CI

02:56am	TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement	NE
09-23	TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana	NE
09-18	TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue	NE
09-01	TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece	NE
08-25	TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap	NE

TempraMed Technologies Ltd. Stock

Stocks

VIVI

CA88024B1022

Medical Equipment, Supplies & Distribution

Chart: TempraMed Technologies Ltd.

Latest news: TempraMed Technologies Ltd.

Press Releases: TempraMed Technologies Ltd.

Quotes and Performance

Price Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Company Profile

Quotes

1 day	+16.67%
1 week	+16.67%
Current month	+50.00%
1 month	+5.00%
3 months	-28.81%
6 months	-47.50%
Current year	-61.11%

1 week	0.36	0.45
1 month	0.27	0.45
Current year	0.27	1.4
1 year	0.27	1.4
3 years	0.27	1.4
5 years	0.27	1.4
10 years	0.27	1.4

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/13/26	Julia Becker	Option	Director	-54,167	0.0690%
7/13/26	Julia Becker	Option	Director	54,167	0.0690%
5/1/26	Julia Becker	Option	Investor Relations Manager	54,167	0.0738%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TEMPRAMED TECHNOLOGIES LTD.	+16.67%	+16.67%	-	-	19.84M
ABBOTT LABORATORIES	-1.96%	-0.69%	-24.17%	+4.16%	179B
MEDTRONIC PLC	-0.67%	-4.27%	-7.24%	+11.05%	114B
CENCORA, INC.	-0.74%	+0.10%	+0.44%	+65.43%	59.59B
BECTON, DICKINSON AND COMPANY	-1.66%	-0.82%	-3.31%	-32.57%	49.72B
HOYA CORPORATION	+2.37%	+3.35%	+10.35%	+49.24%	47.75B
DEXCOM, INC.	-0.11%	-0.48%	+29.64%	+1.68%	33.11B
MEDLINE INC.	+1.11%	+7.99%	-	-	30.09B
WEST PHARMACEUTICAL SERVICES, INC.	-0.40%	+2.20%	+44.14%	-0.25%	26.45B
SARTORIUS STEDIM BIOTECH	+4.96%	+10.05%	+19.03%	-4.85%	22.79B
Average	+1.98%	+2.99%	+8.61%	+11.74%	56.28B
Weighted average by Cap.	-0.51%	+0.09%	-4.16%	+12.35%